Jorey Chernett Acquires 450,000 Shares of Neuronetics (NASDAQ:STIM) Stock

Impact · against what's priced in

Jorey Chernett's acquisition of 450,000 shares of Neuronetics serves as a positive signal of insider confidence. While the purchase size is relatively small compared to his total holding, it provides a baseline valuation floor near $1.33.

STIM+0.20

No priced-in read yet

In context

Major shareholder Jorey Chernett increased his position by 450,000 shares at an average price of $1.33, signaling confidence in the company's valuation.

Read from the article alone

• healthcare
• STIM
• insider buying
• insider trading
• share purchase

Search tags